Research
Montana’s $12,500 fast track for unproven drugs is now open for business
MIT Technology Review · Jul 31, 2026 · 2 min read
If you’ve got a biotech startup, a drug that’s cleared Phase 1 safety testing in maybe a dozen people, and $12,500, Mon...